Rituximab + Lenalidomide
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Rituximab + Lenalidomide, covering 2019-08-13 to 2019-08-13. Get the full timeline:
Most recent: Clinical Trial Update: Rituximab Plus Lenalidomide for Patients With Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma (Follicular Lymphoma and Marginal Zone Lymphoma) [Phase 3]